Despite the fact that the idea of educating the immune system against tumor-specific antigens by using an active immunotherapy such as a vaccine has been pursued by many researchers, consistent clinical data on the effectiveness of anticancer vaccines have not yet been produced. Lack of tumor specific targets, low immunogenicity of the tumorassociated antigens, inappropriate vaccine formulation and large tumor burdens of the vaccinated patients are some of the most frequent reasons accounting for the current disappointing results with anticancer vaccines.1 In chronic myeloid leukemia (CML), the

Bocchia, M., Gentili, S., & Lauria, F. (2002). Is there any role left for p210-derived peptide vaccines in chronic myeloid leukemia?. HAEMATOLOGICA, 87, 675-677.

Is there any role left for p210-derived peptide vaccines in chronic myeloid leukemia?

BOCCHIA, MONICA;
2002

Abstract

Despite the fact that the idea of educating the immune system against tumor-specific antigens by using an active immunotherapy such as a vaccine has been pursued by many researchers, consistent clinical data on the effectiveness of anticancer vaccines have not yet been produced. Lack of tumor specific targets, low immunogenicity of the tumorassociated antigens, inappropriate vaccine formulation and large tumor burdens of the vaccinated patients are some of the most frequent reasons accounting for the current disappointing results with anticancer vaccines.1 In chronic myeloid leukemia (CML), the
File in questo prodotto:
File Dimensione Formato  
85940_UPLOAD.pdf

non disponibili

Tipologia: Altro materiale allegato
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 96.99 kB
Formato Adobe PDF
96.99 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11365/29491
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo